Downregulation of TNF and JAK-STAT results in clinical benefits, including reduced inflammation and cellular senescence, increase in healthy tissue homeostasis, and improved outcomes for myopathies, rheumatoid arthritis, liver diseases, and cancer [69–71]. The gene discussed is SOAT1; the disease is rheumatoid arthritis.